Topic - Endo International Plc

Related Stories

FILE - This Oct. 14, 2015 file photo shows the Food and Drug Administration campus in Silver Spring, Md. On Thursday, July 6, 2017, Endo International PLC, the maker of painkiller Opana ER, said it will pull the extended-release opioid drug off the market, a month after being urged to do so by U.S. regulators because of abuse. (AP Photo/Andrew Harnik, File)

Painkiller maker stops sales at FDA request because of abuse

By LINDA A. JOHNSON - Associated Press

Endo gets US approval for long-acting testosterone

By MATTHEW PERRONE - Associated Press